© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Long before laboratories relied on high-tech solutions for chiral separations, chemists ran into constant headaches trying to untangle tricky enantiomers. In the early 1980s, the world of chromatography saw a real breakthrough. Cyclodextrin-based phases changed the sorting game for scientists. The predecessor to what we now know as ASTEC CYCLOBOND I 2000 RSP built on the realization that molecular shape—and those subtle quirks in how molecules nest—offered an entirely new way to pull apart chiral compounds. Spiraling ahead, ASTEC brought forward the CYCLOBOND series to meet the needs of real separation—sharper peaks, higher resolution, and reproducibility that a lab crew could actually depend on during long, grueling sample runs.
ASTEC CYCLOBOND I 2000 RSP sits in the family of chiral stationary phases used mainly in high-performance liquid chromatography. What sets this specific version apart comes down to the use of beta-cyclodextrin, locked onto a silica support with a stable, rugged linkage. Many analysts who spend long hours looking for that edge in chiral analysis reach for this column because it performs where others simply fail—especially with basic or charged compounds. I’ve watched teams switch over from traditional chiral packings to CYCLOBOND and instantly shave days off method development.
The core of CYCLOBOND I 2000 RSP remains its beta-cyclodextrin surface. These molecules form ring-shaped cavities, which fit snugly around some analytes, “recognizing” them at a molecular level. You feel this effect as sharper, more reliable separations. The silica backbone gives the column its mechanical strength, handling high pressure without breaking down. Each particle measures a handful of microns, providing a huge surface area for interaction with compounds in the mobile phase. Both hydrophilic and hydrophobic standards pass through cleanly, letting it stand up to a range of sample types without the flaring or tailing you often see on older phases.
Manufacturers supply CYCLOBOND I 2000 RSP columns with precise pore size, typically 100 Å, and particle sizes that usually range between 3 to 5 microns. Column dimensions often start at 4.6 mm x 250 mm but also branch out for custom applications. Each label details batch number, particle size, and maximum pressure to keep things transparent for method validation. I’ve run QA audits myself and seen how proper tracking keeps labs in line with regulatory demands and makes troubleshooting much more manageable. Every shipment provides a certificate of analysis and a chromatogram documenting initial performance—a move that lets users compare results over time and spot degradation before it wrecks a crucial assay.
Makers start by physically activating high-purity silica. They then anchor beta-cyclodextrin molecules onto the surface using robust silyl linkages. This chemical bonding won’t wash off during the harshest mobile phase switches. After coupling, the beads bake under controlled heat to fix the structure. I recall many labs that tried home-brewed cyclodextrin columns, only to find the chiral selector leaching off after a week. Factory prep ensures every CC packed in the column stays there, run after run, batch after batch.
The RSP in the column name stands for “Reduced Secondary Position,” a chemical tweak where the hydroxyl groups on the secondary rim of the beta-cyclodextrin receive special attention. This change stabilizes the molecule against harsh solvents and bases, opening the door for direct injections of crude samples that might have once trashed other columns in a single sequence. Over the years, surface chemists experimented with minor ring substitutions or stereochemistry tweaks, inventing entire subtypes that expanded the range of drugs and fine chemicals labs could analyze. Peer-reviewed literature documents the way these modifications improve selectivity and solve problems for method developers working in pharma, forensics, and food safety.
ASTEC CYCLOBOND I 2000 RSP goes by several names in chromatographic circles. Some older catalogs call it ChiraDex RSP. At conferences, experts sometimes use shorthand like “RSP beta-cyclodextrin phase,” but most large suppliers stick to the ASTEC branding for clarity. Switching between distributors rarely changes the underlying chemistry, though users always check batch compatibility to sidestep cross-column surprises.
Every user faces risks handling high-pressure systems and organic solvents. ASTEC columns arrive tested above their rated pressure limit, but in my own experience, staying below 4000 psi extends life and keeps fittings tight. Beta-cyclodextrin itself falls under safe chemical standards by major agencies, but mobile phase additives—acids, bases, acetonitrile, methanol—bring their own set of precautions. Column beds routinely generate huge pressures—enough to burst tubing or fittings if ignored. Regular leak checks, mobile phase filtration, and use of explosion-proof enclosures keep labs safe year-round.
Pharmaceutical R&D sits front and center, with teams needing robust solutions for stereoisomer sorting and purity checking. I’ve spent years in clinical contract labs where CYCLOBOND columns handle routine QC—checking that drugs only contain the active enantiomer. They also find their way into food safety (think sweetener contaminants or flavor analysis), forensic toxicology, and environmental testing of trace-level chiral pesticides. Whenever regulators ask for absolute proof a product doesn’t contain mirror-image contaminants, this column delivers clear, defendable data.
Development teams constantly push the chemistry to handle more types of chiral centers—expanding from amines and alcohols to tough compounds like epoxides and fluoro-organics. Scientists at universities and private labs test new cyclodextrin modifications, improve support materials, and tune particle geometry for sharper peaks. I’ve followed literature where these columns helped discover unknown metabolites in blood, map out natural product pathways, or settle patent disputes over key drug intermediates. With global regulations getting tighter, innovation gets pushed each year, driving the next big leap in column performance.
Thorough studies on beta-cyclodextrin’s toxicity reveal its widespread safety, even when analyzed for prolonged skin contact or accidental ingestion. Researchers rarely find negative effects at levels encountered during standard lab use. The core silica poses more of a dust risk than a chemical hazard, so lab techs wear masks if they repack beds or clean spills. Mobile phases, rather than the stationary phase, contribute most lab risk, particularly if methanol or acetonitrile run hot at high flow. Proper ventilation goes a long way, and having solvent spill kits on hand creates a culture of preparedness rather than panic if something tips over.
With chiral drugs dominating new pharmaceutical pipelines and stricter purity demands across global industries, the need for reliable chiral columns grows every year. Research looks for more rugged surfaces, smaller particles for ultra-high performance, and even hybrid columns that blend several separation strategies on one bed. I see AI entering method development, helping chemists pick the right stationary phase and conditions without months of trial and error. As industries address new legal and ethical demands, total traceability from batch to batch becomes norm rather than exception. CYCLOBOND I 2000 RSP and its next generation versions form the backbone—not just of today’s lab separations, but of a future where clean, unambiguous chemical data shapes science, health, and safety worldwide.
Pharmaceutical labs and research teams in chemistry often have a basic challenge: separating enantiomers. These are molecules that look like mirror images but act in dramatically different ways inside the body. Drug makers can’t cut corners here—having the wrong enantiomer might lead to unexpected side effects or useless medicine. I’ve spent enough time around analytical chemists to understand how they talk about enantiomeric purity as a critical step in developing safe and effective drugs.
The ASTEC CYCLOBOND I 2000 RSP column stands out because it takes a different approach. Instead of using heavy-duty metal complexes or running every sample through a battery of tests, this column uses derivatized beta-cyclodextrin as its stationary phase. Cyclodextrins have a doughnut-shaped cavity, and this structure lets them capture one enantiomer in a way that the other simply doesn’t fit. The “RSP” type adds isopropyl side chains, helping balance solubility and interaction strength. I’ve watched experienced analysts use similar columns to tackle problems that defeated more traditional approaches.
Drug development demands a toolbox that can handle both polar and nonpolar compounds. The CYCLOBOND I 2000 RSP column thrives with polar organic solvents, making it especially good for separating beta-blockers, antihistamines, and certain amino acid derivatives. Stereochemistry isn’t just a curiosity for people in white coats: it’s a regulatory concern worldwide. The FDA, EMA, and other watchdogs insist on proof that new medicines contain just the right enantiomers at every stage. A reliable chiral HPLC column smooths the workflow, bringing clarity and speed to regulatory filing.
Running chiral separations without dependable hardware can feel like painting with a blindfold. Research groups and QC labs need columns that offer both selectivity and repeatability. After all, nobody wants to rerun samples or worry about shifting retention times. The CYCLOBOND I 2000 RSP brings a level of consistency that builds confidence with each test run. In my experience, speed and reproducibility matter most when you’re facing tight timelines and tough deadlines.
Academic researchers often push the limits of chirality, identifying new natural products and probing complex reaction pathways. This column doesn’t just belong in pharmaceutical settings. Agricultural labs screening new crop protection agents, or forensic teams verifying the presence of controlled substances, both find solid value in reliable chiral separation. The flexibility to switch between various mobile phases gives users fewer headaches, opening new doors for method development.
Demand for precise chiral analysis will only continue to climb. More labs want automated systems, greener solvents, and sharper resolution. Tools like the ASTEC CYCLOBOND I 2000 RSP column fill that gap and help researchers move quickly from complex mixtures to clear, actionable results. The everyday use of these columns proves just how closely technology shapes scientific progress—and how lab decisions ripple into safe therapies and innovative discoveries for everyone.
Good chromatography always comes back to a mix of care and know-how. The ASTEC CYCLOBOND I 2000 RSP column, like any specialty phase, thrives on attention to detail. Years in the lab taught me not to ignore the basics. Whether separating chiral or polar compounds, this column shows its best side only within certain hydrodynamic and chemical boundaries.
I’ve spent my share of afternoons staring at HPLC pumps and wondering why baselines wobble. With the CYCLOBOND I 2000 RSP, stable performance starts with respecting pressure limits. The upper end sticks around 4,000 psi or 275 bar, which fits with most modern HPLC setups. Loading more than that means trouble, and trouble always means lost sample, wasted solvent, or worse.
Temperature is another important piece. This column stands up well around 10 to 40°C. Warmth speeds up runs, but pushing past 40°C can knock the stationary phase out of balance, which degrades the cyclodextrin coating. I’ve had colleagues who ignored this and found themselves swapping out columns twice as fast.
What goes through the column matters just as much as flow rate or pressure. Methanol, acetonitrile, and water represent the main starting lineup. These solvents play nice with the cyclodextrin backbone, and most analytes follow suit. I’ve learned to keep the pH moderate—pushing below 2 or above 7.5 shortens column lifespan and disrupts selectivity. It’s tempting to reach for stronger acids or bases when a separation turns stubborn, but it pays off to stay in range.
Buffer choices matter, and using volatile salts like ammonium acetate or ammonium formate works well at concentrations under 10 mM. With higher concentrations, you risk crusty salt deposits that choke up the stationary phase. Phosphate and sulfate buffers create problems, both with precipitation and cleaning headaches later on.
Years of daily use taught me that even sturdy columns feel strain from carelessness. Equilibration time saves headaches. Always flush at least 10 to 20 column volumes of mobile phase before injection—rushing only invites baseline drift and irreproducible retention. At the end of the week, I run a final wash with 100% methanol to rid the column of lingering contaminants. Treat this habit as insurance.
Flow rate tends to land best around 0.5 to 1 mL/min for analytical 4.6 mm inner diameter columns. Running faster strains the stationary phase, especially during start-up. My experience says erring on the slower side gives sharper peaks and steadier pressure. Every crowded sample batch seems to tempt the run at warp speed, but patience always pays in column lifespan and resolution.
Trustworthy data comes only from reliable habits. The CYCLOBOND I 2000 RSP rewards respect for these basic operating principles. With the right solvents, careful temperature control, reasonable pressure, and regular maintenance, these columns keep delivering crisp peaks and reproducible results. As the lab managers drilled into me, excellent separations are built on small, consistent actions. This approach works for every chemist and analyst relying on chiral separations.
The value of careful, measured operation grows every day columns give repeatable profiles. I’ve come to measure proficiency not by how novel the separation is, but by how long the column keeps performing under solid habits.
Walking through the world of chemistry, it’s easy to underestimate just how important it is to separate one mirror-image molecule from another. For anyone developing pharmaceuticals, agricultural chemicals, or certain flavors and fragrances, purity goes beyond just avoiding dirt and dust. It comes down to distinguishing between two siblings with extremely similar faces—chiral enantiomers.
A chiral column does not function like a typical silica-based column. Its surface is treated with a chiral stationary phase, giving it a form of “handedness” that lets it interact differently with each enantiomer of a compound. With the right pairing, it can tease apart compounds that standard columns would treat as identical. Throughout my laboratory experience, watching a poorly resolved racemate slowly separate into clear, distinct peaks is nothing short of rewarding.
Chiral columns show their strength with compounds containing one or more chiral centers. That means molecules with carbon atoms attached to four different groups. These are everywhere in pharmacy, food science, and asymmetric synthesis.
Some classic examples include amino acids. Their natural forms play roles in building proteins, but just a change in orientation—and you could end up with something biologically inactive or even toxic. Another big class is drugs like ibuprofen, where only one enantiomer brings pain relief, and the other either does nothing or, worse, causes side effects. Beta-blockers, antidepressants, and some antifungal agents depend on precise chirality for effectiveness.
Sweeteners and flavors present another side of the coin. Limonene comes in two forms, each giving a different scent, one citrusy and fresh, the other a little more turpentine. Menthol splits this way, too—the cooling effect only holds for one hand, not both.
Not every chiral compound gets along equally well with every column. The interaction relies on molecular shape, the presence of hydrogen bonding sites, and the type of stationary phase used. Cyclodextrin-based stationary phases often excel at pulling apart drugs and steroids. Polysaccharide-based columns step up for compounds with multiple chiral centers or those present in higher complexity, like sugars.
In my own work, sometimes finding optimal separation meant switching through several chiral columns, tweaking the mobile phase composition, or even the temperature, just to get baseline separation. Even milligram quantities matter—a lab director once reminded me that trace amounts of the wrong isomer could sideline an entire drug development project, either through side effects or regulatory hurdles.
Regulations from agencies like the FDA and EMA demand rigorous proof that the active isomer dominates in final formulations. Without chiral columns and robust separation methods, researchers risk spending years on a synthesis pathway, only to find they cannot commercialize what they’ve created. In the food sector, subtle differences shape quality and safety profiles. For agricultural chemicals, one enantiomer may protect yields while the other harms pollinators or persists in soil.
Scaling up chiral resolution brings challenges. Screening work often starts tiny—micrograms—using HPLC or SFC. Pushing a promising candidate to kilogram scales involves prep-scale chromatography, crystallization, or even enantioselective synthesis. Yet, everything begins with proof: separating those chiral compounds in the first place.
Choice of chiral stationary phase forms the backbone of any solid separation method. Success depends on chemistry, not just equipment. Knowing which molecules separate, and how, creates opportunities where science turns into life-changing products.
I’ve spent years in labs watching how a small shift in particle size can flip an entire separation outcome upside down. Fine particles help achieve sharper peaks and more efficient separations. Every analyst knows the frustration when sample resolution falls short or pressure climbs because of the wrong packing material. For ASTEC CYCLOBOND I 2000 RSP, these practical concerns stay front and center.
ASTEC CYCLOBOND I 2000 RSP usually comes packed with particles of 5 microns. This isn’t random. A 5-micron size strikes a balance between column backpressure and separation performance. Looking for greater speed and a tighter separation? Sub-2 micron sizes now exist on the market—but these demand costly UHPLC equipment and ratchet up system pressure. Most routine HPLC work, especially in chiral separations where this phase shines, gets the consistency and durability it needs from that 5-micron build.
The silica surface area comes out to about 300 square meters per gram. Pore size is about 120 angstroms, which fits most small-molecule applications. If you’ve tried pushing larger biomolecules through these particles, you might have seen clogging or odd retention times. Staying within the range of small molecule analysis avoids these snags.
ASTEC CYCLOBOND I 2000 RSP isn’t hemmed in to one column configuration. Commonly, labs reach for columns in lengths like 150 mm and 250 mm. Internal diameters often end up at 4.6 mm—an old standby for most HPLC systems. For more targeted needs, the material can be found in narrower 2.1 mm columns for higher sensitivity and lower solvent use.
Preparative-scale work calls for bigger internal diameters, up to 10 mm or more, handy for collecting milligram or gram quantities of pure isomer. With more labs moving to smaller sample sizes, 2.1 mm columns have seen increased interest, especially alongside micro- and nano-HPLC setups. It’s rare to bump up against a size request that can’t be met—ASTEC has kept its catalog broad for this reason.
Why fuss over particle size or column dimension at all? The proof sits in the results. Smaller particles create tighter bands on a chromatogram and pull out close eluting species. If your lab often faces chiral challenges—think of separating drug enantiomers for regulatory submissions—these differences make or break a project. Efficiency gains can also mean reduced solvent use and faster run times, easing budgets and cleanup.
There's a catch. Finer particles, though great for separation, hike up the system pressure. Old pumps and fittings may struggle, and sudden blockages can grind analyses to a halt. Sticking with 5-micron material on a classic 4.6 mm column dodges most hardware headaches.
Picking particle size and column dimensions isn’t just about specs. The call depends on what fits your analytical workflow, budget, and the quirks of your instruments. If you’re setting up a new method or troubleshooting an old one, start with the tried-and-true: 5-micron particles packed into a 150 mm or 250 mm long, 4.6 mm diameter column. My own best results came when I matched the hardware limits to the chromatography goals, giving plenty of breathing room both in pressures and budgets.
Keep an eye on advancements, as manufacturers continuously tinker with materials and dimensions. Yet in my years at the bench, those classic 5-micron, 4.6 mm diameter columns still show up again and again for a reason—they simply get the job done for most chiral separations without demanding costly upgrades or daily troubleshooting.
Lab work demands consistency and reliability, especially in chromatography. Anyone who has spent long hours troubleshooting strange peaks or fading signals knows how much hassle a poorly kept column can bring. The ASTEC CYCLOBOND I 2000 RSP column brings sensitivity and sharp resolution to chiral separations, but like any top tool, it calls for some respect and simple routine.
This column uses a derivatized cyclodextrin bonded to silica. Silica-based supports can dry out, pack with unwanted residues, or degrade if stored in harsh solvents. Each of these knocks down the performance and shortens column life. Right after use, flushing the column becomes just as important as running samples. A method that’s worked for me is washing with a series of compatible solvents. By flushing with at least ten column volumes of a weak solvent—often acetonitrile/water mix at a moderate ratio—you clear away most potential carryover or late-eluting junk.
Avoid strong acids or bases. The stationary phase holds up well to reasonable use, but strong pH extremes start breaking it down. Keeping within a pH window between 3 and 7.5 usually staves off irreversible damage.
If the column will only sit for a day or two, storing it in the mobile phase works just fine, assuming the buffer or additives are mild and won’t crystallize. In cases where buffers or salts are present, flushing with a pure organic solvent like acetonitrile prevents salt buildup, which clogs lines and fouls up the inlet frit.
A column that sits more than a week without use deserves a bit more care. My go-to step involves flushing first with a mixture that matches the last used mobile phase, switching next to 100% acetonitrile, or a mix recommended by the manufacturer that contains at least 50% acetonitrile. This keeps both the silica support and the cyclodextrin phase hydrated and protected from air. Once flushed, sealing the ends tightly stops solvent evaporation and air ingress, the two biggest threats during shelf time. For best results, store the column horizontally in a drawer or cabinet, away from direct sunlight and vibration.
Over years at the bench, I’ve learned that cutting corners on daily maintenance leads to headaches down the line. Filtering all samples and mobile phases through a 0.2 μm or 0.45 μm membrane filter blocks particulates and microbial growth before they start. Using a guard column extends main column life by trapping larger debris early.
Columns speak their own language: rising pressure, dropping response, or weird peak shapes all signal something isn’t right. Don’t ignore these signs. Regular checks of back pressure and retention times pay off—catching issues before they force emergency replacements. If performance dips, a gentle flush with half acetonitrile and half water can knock free mild deposits, restoring function for several more runs.
Reliable chromatography results ask for good habits and user attention. With the ASTEC CYCLOBOND I 2000 RSP column, protecting the stationary phase, flushing regularly, storing properly, and filtering everything before injection form a foundation that holds up over time. This approach not only saves money lost to damaged columns but also helps ensure every run counts.
| Names | |
| Preferred IUPAC name | (2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(propylsulfonyl)oxytetrahydro-2H-pyran-3,4,5-triol |
| Other names |
Cyclobond I 2000 RSP Cyclobond I 2000 RSP Chiral HPLC Column |
| Pronunciation | /ˈæs.tɛk ˈsaɪ.kloʊˌbɒnd aɪ tuː ˈθaʊ.zənd ɑːr ɛs piː ˈkaɪ.rəl eɪtʃ piː ɛl/ |
| Identifiers | |
| CAS Number | 126139-04-0 |
| 3D model (JSmol) | `3D model (JSmol)`: `Cyclodextrin-[C6H10O5]n` |
| Beilstein Reference | 4128838 |
| ChEBI | CHEBI:60004 |
| ChEMBL | CHEMBL4296361 |
| ChemSpider | 168138 |
| DrugBank | DB11443 |
| ECHA InfoCard | echa infocard 100.256.324 |
| EC Number | 16166012 |
| Gmelin Reference | 12991873 |
| KEGG | C20175 |
| MeSH | D08.811.277.352.650.200 |
| PubChem CID | 71307866 |
| RTECS number | NLV4844000 |
| UNII | 9GNG3H1PO1 |
| UN number | UN1993 |
| CompTox Dashboard (EPA) | CXT17674 |
| Properties | |
| Molar mass | 494.58 g/mol |
| Appearance | White powder |
| Odor | Odorless |
| Density | 0.98 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 1.90 |
| Acidity (pKa) | 14.10 |
| Basicity (pKb) | 12.1 |
| Refractive index (nD) | 1.333 |
| Viscosity | 12 cP |
| Dipole moment | 0.00 D |
| Pharmacology | |
| ATC code | V07AY |
| Hazards | |
| GHS labelling | GHS02, GHS07, GHS08, Danger, H225, H315, H319, H336, H361 |
| Pictograms | “GHS07” |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: P261, P264, P271, P280, P301+P312, P305+P351+P338, P337+P313, P304+P340, P312 |
| Flash point | Flash point: 199.6 °F |
| NIOSH | AS0142150 |
| REL (Recommended) | 50 mm |
| Related compounds | |
| Related compounds |
ASTEC CYCLOBOND I 2000 ASTEC CYCLOBOND I 2000 SP ASTEC CYCLOBOND I 2000 HP ASTEC CYCLOBOND I 2000 DM |
